Literature DB >> 17524293

Chlamydia trachomatis prevalence in heterosexual men in Melbourne: a community-based study.

Amanda J Wade, Jane S Hocking, Margaret E Hellard.   

Abstract

There is limited information about chlamydia prevalence in men. Our study aimed to measure the prevalence of chlamydia in 16-29-year-old heterosexual men. Recruitment was undertaken through urban sporting clubs. Participants were approached after training to complete a questionnaire and to provide a urine sample that was tested for Chlamydia trachomatis. Participants with positive results received treatment. Fifty participants were recruited and four were found to be infected (8.5%, 95% CI 2.76-21.27). There was a high prevalence of C. trachomatis in our study participants, highlighting the importance of including men in chlamydia response programs.

Entities:  

Mesh:

Year:  2007        PMID: 17524293     DOI: 10.1071/sh07008

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  3 in total

1.  Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009.

Authors:  Lenka A Vodstrcil; Christopher K Fairley; Glenda Fehler; David Leslie; Jennifer Walker; Catriona S Bradshaw; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2011-06-05       Impact factor: 3.090

2.  The SPORTSMART study: a pilot randomised controlled trial of sexually transmitted infection screening interventions targeting men in football club settings.

Authors:  Sebastian S Fuller; Catherine H Mercer; Andrew J Copas; John Saunders; Lorna J Sutcliffe; Jackie A Cassell; Graham Hart; Anne M Johnson; Tracy E Roberts; Louise J Jackson; Pamela Muniina; Claudia S Estcourt
Journal:  Sex Transm Infect       Date:  2014-12-15       Impact factor: 3.519

Review 3.  The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis.

Authors:  Dyani Lewis; Danielle C Newton; Rebecca J Guy; Hammad Ali; Marcus Y Chen; Christopher K Fairley; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.